Clinical trial
Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study
NCT05384678 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 15, 2022
- Completion date
- March 13, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy